Planned sale of 6,327 common shares by insider

Form 144 reports a planned insider sale of 6,327 common shares.

Accepted by SEC EDGAR 02/10/2026 - 05:23 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Form 144 reports a planned insider sale of 6,327 common shares. The shares are to be sold through Raymond James & Associates, with an aggregate market value of $311,068.23, and an approximate sale date of February 10, 2026 on the NASDAQ market.

The 6,327 shares of common stock were acquired on January 22, 2025 as part of a restricted stock unit (RSU) award from the issuer. The filing also notes prior sales of common shares over the past three months by Stefan Murry, listing several transactions with their respective dates, share amounts, and gross proceeds.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does this Form 144 filing for AAOI disclose?

The Form 144 filing discloses a planned sale of 6,327 common shares with an aggregate market value of $311,068.23. The shares are expected to be sold on the NASDAQ through Raymond James & Associates on or around February 10, 2026.

How many AAOI shares are planned to be sold and at what value?

The filing shows a planned sale of 6,327 common shares with an aggregate market value of $311,068.23. This reflects the market value at the time of the notice and indicates the size of the proposed transaction relative to the issuer’s total outstanding shares.

How and when were the AAOI shares in this Form 144 acquired?

The 6,327 common shares were acquired on January 22, 2025 via a restricted stock unit (RSU) transaction from the issuer. The same date is listed as the date of payment, with the nature of payment described as N/A, consistent with equity compensation awards.

Which broker and exchange are involved in this AAOI Form 144 sale?

The planned sale will be executed through Raymond James & Associates, located in St. Petersburg, Florida. The shares are to be sold on the NASDAQ securities exchange, as specified in the filing’s securities information section for the common stock class.

What AAOI share sales occurred in the past three months for this insider?

The filing lists several past three-month sales by Stefan Murry in AAOI common stock, including transactions on December 10, 2025, January 12, 2026, January 13, 2026, and January 15, 2026, each with specified share amounts and related gross proceeds.

How many AAOI shares are outstanding according to this filing?

The Form 144 indicates that 68,279,888 common shares are outstanding. This figure provides context for evaluating the size of the planned 6,327-share sale relative to the issuer’s total equity base at the time of the notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001587599
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	APPLIED OPTOELECTRONICS, INC.
SEC File Number	001-36083
Address of Issuer	13139 JESS PIRTLE BLVD SUGAR LAND TEXAS 77478
Phone	281-295-1800
Name of Person for Whose Account the Securities are To Be Sold	Murry Stefan J.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	6327	311068.23	68279888	02/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/22/2025	RSU	Issuer			6327	01/22/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Stefan Murry 2007 Milford St Houston TX 77098	Common	12/10/2025	4000	126213.00
Stefan Murry 2007 Milford St Houston TX 77098	Common	01/12/2026	3000	101242.00
Stefan Murry 2007 Milford St Houston TX 77098	Common	01/13/2026	934	32690.00
Stefan Murry 2007 Milford St Houston TX 77098	Common	01/15/2026	66	2311.00

144: Remarks and Signature

Remarks
Date of Notice	02/10/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Maressia Rooks-Bailey, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Stefan John Murry
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)